Patents by Inventor Nurit MERON

Nurit MERON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL OMNI-50 CRISPR NUCLEASE
    Publication number: 20240131121
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 3 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: April 5, 2023
    Publication date: April 25, 2024
    Applicant: EmendoBio Inc.
    Inventors: David Baram, Lior Izhar, Asael Herman, Liat Rockah, Nadav Marbach-Bar, Nurit Meron, Joseph Georgeson
  • OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleases
    Patent number: 11946077
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-8 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: April 2, 2024
    Inventors: Lior Izhar, Liat Rockah, Nadav Marbach Bar, Nurit Meron
  • NOVEL OMNI 56, 58, 65, 68, 71, 75, 78, AND 84 CRISPR NUCLEASES
    Publication number: 20230383273
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 90% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-8 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: October 20, 2021
    Publication date: November 30, 2023
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Liat Rockah, Nadav Marbach Bar, Nurit Meron
  • OMNI-103 CRISPR NUCLEASE
    Publication number: 20230303989
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: February 7, 2022
    Publication date: September 28, 2023
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch, Nir Hecht
  • CRISPR nuclease
    Patent number: 11666641
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 3 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: June 6, 2023
    Assignee: EMENDOBIO INC.
    Inventors: David Baram, Lior Izhar, Asael Herman, Liat Rockah, Nadav Marbach-Bar, Nurit Meron, Joseph Georgeson
  • NOVEL OMNI-59, 61, 67, 76, 79, 80, 81, AND 82 CRISPR NUCLEASES
    Publication number: 20230122086
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-8 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: June 4, 2021
    Publication date: April 20, 2023
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Liat Rockah, Nadav Marbach Bar, Nurit Meron
  • NOVEL OMNI CRISPR NUCLEASES
    Publication number: 20220213456
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-4 or 149-166 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: April 30, 2020
    Publication date: July 7, 2022
    Applicant: EmendoBio Inc.
    Inventors: David Baram, Lior Izhar, Asael Herman, Liat Rockah, Nadav Marbach-Bar, Nurit Meron, Joseph Georgeson
  • NOVEL OMNI-50 CRISPR NUCLEASE
    Publication number: 20220202913
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 3 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: April 30, 2020
    Publication date: June 30, 2022
    Applicant: EmendoBio Inc.
    Inventors: David Baram, Lior Izhar, Asael Herman, Liat Rockah, Nadav Marbach-Bar, Nurit Meron, Joseph Georgeson
  • ASSAY FOR THE REMOVAL OF METHYL-CYTOSINE RESIDUES FROM DNA
    Publication number: 20190100732
    Abstract: An isolated polynucleotide encoding a fusion protein which comprises a catalytically inactive CRISPR associated 9 (dCas9) protein linked to a TET protein is disclosed. Use thereof and of the fusion protein itself is also disclosed.
    Type: Application
    Filed: June 2, 2017
    Publication date: April 4, 2019
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Asaf HELLMAN, Nurit MERON